StonvexLoading…
StonvexStonvexStonvexCore line items from BCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £11.11B | £10.71B | £9.98B | £9.49B |
Operating Income | £9.14B | £8.11B | £6.56B | £7.01B |
Net Income | £7.21B | £6.36B | £5.32B | £5.97B |
EPS (Diluted) | £0.42 | £0.35 | £0.27 | £0.30 |
Total Assets | £1.54T | £1.52T | £1.48T | £1.51T |
Total Liabilities | £1.47T | £1.45T | £1.41T | £1.44T |
Cash & Equivalents | £256.46B | £235.61B | £248.01B | £278.79B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |